Trial intelligence / Profile preview

Paliperidone Augmentation of Clozapine in Resistant Schizophrenia

NCT01279213Phase 4Completed

Sponsor
Universidad Nacional de Rosario
Start
Jan 2009
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paliperidone in schizophrenia, sponsored by Universidad Nacional de Rosario. Started Jan 2009; status: completed.

02

Drugs

paliperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01279213.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01279213.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call